Cargando…
Design and Synthesis of LM146, a Potent Inhibitor of PB1 with an Improved Selectivity Profile over SMARCA2
[Image: see text] PB1 is a bromodomain-containing protein hypothesized to act as the nucleosome-recognition subunit of the PBAF complex. Although PB1 is a key component of the PBAF chromatin remodeling complex, its exact role has not been elucidated due to the lack of potent and selective inhibitors...
Autores principales: | Mélin, Léa, Gesner, Emily, Attwell, Sarah, Kharenko, Olesya A., van der Horst, Edward H., Hansen, Henrik C., Gagnon, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387997/ https://www.ncbi.nlm.nih.gov/pubmed/34471737 http://dx.doi.org/10.1021/acsomega.1c01555 |
Ejemplares similares
-
RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist
por: McLure, Kevin G., et al.
Publicado: (2013) -
MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5
por: Wang, Haiyang, et al.
Publicado: (2020) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023) -
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022) -
Expression of murine Lm-1 locus. Lm-1 determinants on lymphocytes and macrophages, and effects of Lm-1 incompatibility on bone marrow grafts
Publicado: (1985)